Can-Fite BioPharma Reports First Quarter 2014 Results
PETACH TIKVA, Israel, May 29, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today reported financial results for the first quarter ended March 31, 2014.
Help employers find you! Check out all the jobs and post your resume.